Literature DB >> 7908320

Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice.

A M Jevnikar1, M J Grusby, L H Glimcher.   

Abstract

MRL-lpr mice develop aggressive autoimmune kidney disease associated with increased or de novo renal expression of major histocompatibility complex (MHC) class II molecules and a massive systemic expansion of CD4-CD- double negative (DN) T cells. Whereas non-MHC linked genes can have a profound effect on the development of nephritis, lymphadenopathy, and anti-DNA antibody production in MRL-lpr mice, the role of MHC molecules has not been unequivocally established. To study the role of MHC class II in this murine model of systemic lupus erythematosis, class II-deficient MRL-lpr mice (MRL-lpr -/-) were created. MRL-lpr -/- mice developed lymphadenopathy but not autoimmune renal disease or autoantibodies. This study demonstrates that class II expression is critical for the development of autoaggressive CD4+ T cells involved in autoimmune nephritis and clearly dissociates DN T cell expansion from autoimmune disease initiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908320      PMCID: PMC2191453          DOI: 10.1084/jem.179.4.1137

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

Review 1.  Etiopathogenesis of murine SLE.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

2.  Prevention of lymphadenopathy in MRL-lpr/lpr mice by blocking peripheral lymph node homing with Mel-14 in vivo.

Authors:  J D Mountz; W C Gause; F D Finkelman; A D Steinberg
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

3.  B lymphocyte development and activation independent of MHC class II expression.

Authors:  J S Markowitz; P R Rogers; M J Grusby; D C Parker; L H Glimcher
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

4.  Induction of various autoantibodies by mutant gene lpr in several strains of mice.

Authors:  S Izui; V E Kelley; K Masuda; H Yoshida; J B Roths; E D Murphy
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

5.  Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.

Authors:  T Zhou; H Bluethmann; J Eldridge; K Berry; J D Mountz
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

6.  CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.

Authors:  J D Mountz; H R Smith; R L Wilder; J P Reeves; A D Steinberg
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

7.  Clonal diversity and T-cell receptor beta-chain variable gene expression in enlarged lymph nodes of MRL-lpr/lpr lupus mice.

Authors:  P A Singer; R J McEvilly; D J Noonan; F J Dixon; A N Theofilopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

8.  Autoreactive kidney-infiltrating T-cell clones in murine lupus nephritis.

Authors:  C Díaz Gallo; A M Jevnikar; D C Brennan; S Florquin; A Pacheco-Silva; V R Kelley
Journal:  Kidney Int       Date:  1992-10       Impact factor: 10.612

9.  Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci.

Authors:  M L Watson; J K Rao; G S Gilkeson; P Ruiz; E M Eicher; D S Pisetsky; A Matsuzawa; J M Rochelle; M F Seldin
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

10.  Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express L3T4.

Authors:  D A Jabs; R A Prendergast
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  50 in total

1.  Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.

Authors:  Anthony D Foster; Mark Haas; Irina Puliaeva; Kateryna Soloviova; Roman Puliaev; Charles S Via
Journal:  Clin Immunol       Date:  2010-05-06       Impact factor: 3.969

2.  Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance.

Authors:  Brian W Busser; Brigette S Adair; Jan Erikson; Terri M Laufer
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

3.  Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus-like autoimmunity.

Authors:  William Stohl; Noam Jacob; Shunhua Guo; Laurence Morel
Journal:  Arthritis Rheum       Date:  2010-08

Review 4.  T cells and B cells in lupus nephritis.

Authors:  Mary H Foster
Journal:  Semin Nephrol       Date:  2007-01       Impact factor: 5.299

5.  Proliferation of CD3+ B220- single-positive normal T cells was suppressed in B-cell-deficient lpr mice.

Authors:  T Akashi; S Nagafuchi; K Anzai; D Kitamura; J Wang; I Taniuchi; Y Niho; T Watanabe
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

6.  MHC class I polymorphism in lupus-prone MRL/Mp mice.

Authors:  S L Peng; J Craft
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

7.  Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus.

Authors:  T Yoshimasu; T Nishide; N Seo; A Hiroi; T Ohtani; K Uede; F Furukawa
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

8.  ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.

Authors:  Jared M Odegard; Leah D DiPlacido; Lark Greenwald; Michael Kashgarian; Dwight H Kono; Chen Dong; Richard A Flavell; Joe Craft
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

9.  Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus.

Authors:  Lino L Teichmann; Dominik Schenten; Ruslan Medzhitov; Michael Kashgarian; Mark J Shlomchik
Journal:  Immunity       Date:  2013-03-14       Impact factor: 31.745

10.  CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus.

Authors:  Roman Puliaev; Irina Puliaeva; Lisbeth A Welniak; Abigail E Ryan; Mark Haas; William J Murphy; Charles S Via
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.